- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
A high-profile decades-long type 2 diabetes study grant to Columbia University as of Monday (March 24) morning remained canceled despite the university's reported agreement Friday (March 21) to acquiesce to the Trump administration’s political demands in a bid to get hundreds of millions of dollars in canceled NIH grants restored, a principal investigator on the study confirmed to Inside Health Policy, putting continuity of the major diabetes study potentially in danger.
Advertisement
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us